[Seite 159↓]

Literaturverzeichnis

(1) Anonymous. Propranolol for prevention of migraine headaches. Med Lett Drugs Ther 1979; 21: 77-78.

(2) Anonymous. Cochrane Reviewers Handbook 4.1.3 (updated June 2001). Clarke M, Oxman AD, Herausgeber. The Cochrane Library, issue 3, 2001. Oxford: Update Software.

(3) Agnoli A, Bussone G, Mailland F, Manzoni GCMN, Nappi G. Dihydroergokryptine vs flunarizine in the basic treatment of migraine without aura. Cephalalgia 1991; 11 (suppl 11): 216-217.

(4) Agrawal A, Dixit SP, Dubey GP, Gupta BS. Clinical evaluation of anti-depressant properties of basant (Hypericum perforatum). Pharmacopsychoecologia 1994; 7: 253-256.

(5) Ahonen E, Hakumäki M, Mahlamäki S et al. Effectiveness of acupuncture and physiotherapy on myogenic headache: a comparative study. Acupunct Electrother Res Int J 1984; 9: 141-150.

(6) Ahuja GK, Verma AK. Propranolol in prophylaxis of migraine. Indian J Med Res 1985; 82: 263-265.

(7) Aikins-Murphy P. Alternative therapies for nausea and vomiting of pregnancy. Obstet Gynecol 1998; 91: 149-155.

(8) Al-Deeb SM, Biary N, Bahou Y, al-Jaberi M, Khoja W. Flunarizine in migraine: a double-blind placebo-controlled study (in a Saudi population). Headache 1992; 32: 461-462.

(9) Al-Qassab HK, Findley LJ. Comparison of propranolol LA 80 mg and propranolol LA 160 mg in migraine prophylaxis: a placebo controlled study. Cephalalgia 1993; 13: 128-131.

(10) Albers GW, Simon LT, Hamik A, Peroutka SJ. Nifedipine versus propranolol for the initial prophylaxis of migraine. Headache 1989; 294: 215-218.

(11) Albertini H. Evaluation d'un traitement homéopathique de la nevralgie dentaire. In: Boiron J, Belon P, Hariveau E, Hrsg. Recherche en homéopathie. Lyon: Fondation francaise pour la recheche en homéopathie, 1986: 75-77.

(12) Allais G, De Lorenzo C, Quirico PE, Lupi G, Ciochetto D, Benedetto C. Acupuncture versus flunarizine in the prophylactic treatment of migraine without aura: A randomized controlled trial. Cephalalgia 1997; 17: 442-443.


[Seite 160↓]

(13) Amery WK. Flunarizine, a calcium channel blocker: a new prophylactic drug in migraine. Headache 1983; 23: 70-74.

(14) Amery WK. Onset of action of various migraine prophylactics. Cephalalgia 1988; 8 (suppl 8): 11-13.

(15) Amery WK, Caers LI, Aerts TJ. Flunarizine, a calcium entry blocker in migraine prophylaxis. Headache 1985; 25: 249-254.

(16) Andersson PG. Flunarizine and propranolol in the treatment of migraine - a double-blind trial. J Neurol 1985; 232 (suppl): 220.

(17) Andersson PG, Dahl S, Hansen JH et al. Prophylactic treatment of classical and non-classical migraine with metoprolol--a comparison with placebo. Cephalalgia 1983; 34: 207-212.

(18) Andersson PG, Petersen EN. Propranolol and femoxetine, a HT-uptake inhibitor, in migraine prophylaxis. A double-blind crossover study. Acta Neurol Scand 1981; 64: 280-288.

(19) Araujo MS. Does the choice of placebo determine the results of clinical studies on acupuncture? A meta-analysis of 100 clinical trials. Forsch Komplementärmed 1998; 5 (suppl 1): 8-11.

(20) Armstrong NC, Ernst E. The treatment of eczema with Chinese herbs: a systematic review of randomized controlled trials. Br J clin Pharmacol 1999; 48: 262-264.

(21) Arzneimittelkommission der deutschen Ärzteschaft. Handlungsleitlinie - chronische Kopfschmerzen. Z ärztl Fortbild Qualsich 1997; 91: 747-750.

(22) Askie L. Broad versus narrow questions: empirical evidence of lumping and splitting in Cochrane perinatal reviews. The Cochrane Methodology Register in The Cochrane Library, issue 3, 2001. Oxford: Update Software.

(23) Bailar JC. The promise and problems of meta-analysis. N Engl J Med 1997; 337: 559-560.

(24) Baischer W. Acupuncture in migraine: Long-term outcome and predicting factors. Headache 1995; 35: 472-474.

(25) Baker C. Double-blind evaluation of flunarizine and placebo in the prophylactic treatment of migraine. Headache 1987; 27: 288.


[Seite 161↓]

(26) Baldrati A, Cortelli P, Procaccianti G et al. Propranolol and acetylsalicylic acid in migraine prophylaxis. Double-blind crossover study. Acta Neurol Scand 1983; 67: 181-186.

(27) Banerjee M, Findley LJ. Propranolol in the treatment of acute migraine attacks. Cephalalgia 1991; 4: 193-196.

(28) Barnes J, Resch KL, Ernst E. Homeopathy for postoperative ileus? A meta-analysis. J Clin Gastroenterol 1997; 25: 628-633.

(29) Barrett B, Vohmann M, Calabrese C. Echinacea for upper respiratory infection. J Fam Pract 1999; 48: 628-635.

(30) Bassi P, Brunati L, Rapuzzi B, Alberti E, Mangoni A. Low dose flunarizine in the prophylaxis of migraine. Headache 1992; 32: 390-392.

(31) Batra YK. Acupuncture in the treatment of migraine. Am J Acupunct 1986; 14: 135-137.

(32) Baust W, Stürtzbecher H. Akupunkturbehandlung der Migräne im Doppelblindversuch. Med Welt 1978; 29: 669-673.

(33) Beck R. Die kontrollierten Effizienzstudien: ein tabellarischer Überblick. AKU 1996; 24: 205-207.

(34) Begg C, Cho M, Eastwood S et al. Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA 1996; 276: 637-639.

(35) Behan PO, Reid M. Propranolol in the treatment of migraine. Practitioner 1980; 224: 201-204.

(36) Bendre VV, Dharmadhikari SD. Arnica montana and hypericum in dental practice. Hahnemann Gleanings 1980 (ohne Bandangabe): 70-72.

(37) Benson K, Hartz AJ. A comparison of observational studies and randomized, controlled trials. N Engl J Med 2000; 342: 1878-1886.

(38) Bergmann R, Nüßner J, Demling J. Behandlung leichter bis mittelschwerer Depressionen. TW Neurol Psychiatr 1993; 7: 235-240.

(39) Berman B, Ezzo J, Hadhazy V, Swyers JP. Is acupuncture effective in the treatment of fibromyalgia? Family Practice 1999; 48: 213-218.

(40) Bernhardt M, Liske E, Ebeling L. Hypericum perforatum in der Therapie leichter bis mittelschwerer Depressionen: Vergleich der antidepressiven Wirksamkeit von zwei unterschiedlichen Dosierungsschemata. Unpublizierter Bericht, 1994.


[Seite 162↓]

(41) Bernik V, Maia E. Uso do propranolol na profilaxia da enxacequa: Estudo duplo-cego comparando propranolol a um analgesico (acetaminofen) e placebo. Folha Med 1978; 77: 501-508.

(42) Boivie J, Brattberg G. Are there long lasting effects on migraine headache after one series of acupuncture treatments? Am J Chin Med 1987; 15: 69-75.

(43) Bono G, Manzoni GC, Martucci N et al. Flunarizine in common migraine: Italian cooperative trial. II. Long-term follow-up. Cephalalgia 1985; 5 (suppl 2): 155-158.

(44) Bonuso S, Di-Stasio E, Marano E et al. Long-term outcome of migraine therapy: predictive value of the frontotemporal nitroglycerin test. Neurology 1998; 51: 1475-1478.

(45) Bordini CA, Arruda MA, Ciciarelli MC, Speciali JG. Propranolol vs flunarizine vs flunarizine plus propranolol in migraine without aura prophylaxis. A double-blind trial. Arq Neuropsiquiatr 1997; 55(3B): 536-541.

(46) Borgesen SE. Treatment of migraine with propranolol. Postgrad Med J 1976; 52 (suppl 4): 163-165.

(47) Borgesen SE, Nielsen JL, Moller CE. Prophylactic treatment of migraine with propranolol. A clinical trial. Acta Neurol Scand 1974; 50: 651-656.

(48) Borgesen SE, Nielsen JL, Moller CE. Propranolol in migraine. Lancet 1974; II: 58.

(49) Boyle P, Robertson C, Lowe F, Roehborn C. Meta-analysis of clinical trials of Permixon in the treatment of symptomatic benign prostata hyperplasia. Urology 2000; 55: 533-539.

(50) Brenner R, Azbel V, Madhusoodanan S, Pawlowska M. Comparison of an extract of hypericum (LI 160) and sertraline in the treatment of depression: a double-blind-randomized pilot study. Clin Ther 2000; 22: 411-419.

(51) Brewington V, Smith M, Lipton D. Acupuncture as a detoxification treatment: an analysis of controlled research. J Alt Complement Med 1994; 11: 289-307.

(52) Brockmöller J, Reum T, Bauer S, Kerb R, Hübner WD, Roots I. Hypericin and pseudohypericin: pharmacokinetics and effects on photosensitivity in humans. Pharmacopsychiatry 1997; 30 (suppl 2 ): 94-101.

(53) Budeiri D, Li Wan Po A, Dornan JC. Is Evening Primrose Oil of value in the treatment of premenstrual syndrome? Contr Clin Trials 1996; 17: 60-68.


[Seite 163↓]

(54) Bussone G, Baldini S, D'Andrea G et al. Nimodipine versus flunarizine in common migraine: a controlled pilot trial. Headache 1987; 27: 76-79.

(55) Canepari C, Riva M, Erminio F. Effectivenes of flunarizine in chronic headache. A double-blind comparison with placebo and amitriptyline. Clin Ter 1985; 115: 463-468.

(56) Carlsson CPO, Sjölund BH. Acupuncture and subtypes of chronic pain: assessment of long-term results. Clin J Pain 1994; 10: 290-295.

(57) Carlsson J, Fahlcrantz A, Augustinsson LE. Muscle tenderness in tension headache treated with acupuncture or physiotherapy. Cephalalgia 1990; 10: 131-141.

(58) Carroll JD, Reidy M, Savundra PA, Cleave N, McAinsh J. Long-acting propranolol in the prophylaxis of migraine: a comparative study of two doses. Cephalalgia 1990; 10: 101-105.

(59) Ceccherelli F, Altafini L, Rossato M et al.: Trattamento agopunturale dell'emicrania senz'aura. Studio in doppio cieco vs placebo. Proceedings XV Congresso Nazionale, AISD Associazione Italiana per lo Studio del Dolore, S. Margherita Ligure , 1992, 310-318.

(60) Ceccherelli F, Ambrosio F, Altopiedi A et al. Trattamento agopunturale delle cefalee. Min Riflessoter Laserter 1985; 2: 45-59.

(61) Ceccherelli F, Cavallo C, Ambrosio F, Altopiedi A, Moro-Boscolo E, Giron GP. Psychologische Untersuchung bei Patienten mit chronischem Schmerz, die mit Akupunkturreflextherapie behandelt wurden. Dtsche Ztschr Akup 1983; 5: 105-112.

(62) Center for Clinical Health Policy Research, Duke University. Drug treatments for the prevention of migraine. Technical review 2.3. Rockville (MD): Agency for Health Care Policy and Research, 1999. Available from the National Technical Information Service, Springfield, VA 22161.

(63) Centonze V, Macinagrossa G, Attolini E et al. Terapia preventiva dell'emicrania: flunarizina versus verapamil. Clin Ter 1985; 115: 333-339.

(64) Cerbo R, Casacchia M, Formisano R et al. Studio clinico in doppio cieco: flunarizina contro pizotifene in un'unica somministrazione serale in pazienti emicranici. Riv Neurol 1985; 55: 139-146.

(65) Cerbo R, Casacchia M, Formisano R et al. Flunarizine-pizotifen single-dose double-blind cross-over trial in migraine prophylaxis. Cephalalgia 1986; 6: 15-18.


[Seite 164↓]

(66) Chalmers TC, Berrier J, Sacks HS, Levin H, Reitman D, Nagalingam R. Meta-analysis of clinical trials as a scientific discipline: II: Replicate variability and comparison of studies that agree and disagree. Stat Med 1987; 6, 733-744.

(67) Chen GS, Hwang YC. Therapeutic effect of acupuncture for chronic pain. Am J Chin Med 1977; 5: 45-61.

(68) Cheng ACK. The treatment of headaches employing acupuncture. Am J Chin Med 1975; 3: 181-185.

(69) Choi PT, Halpern SH, Malik N, Jadad AR, Tramer MR, Walder B. Examining the evidence in the anesthesia literature: a critical appraisal of systematic reviews. Anesth Analg 2001; 92: 700-709.

(70) Clarke MJ, Stewart LA. Obtaining individual patient data from randomised controlled trials. In: Egger I, Smith GD, Altman DG, Hrsg. Systematic reviews in health care: meta-analysis in context. London: BMJ Books, 2001: 109-121.

(71) Clausius N. Kontrollierte klinische Studien zur Homöopathie. Eine systematische Übersichtsarbeit mit Metaanalyse. Essen: KVC Verlag - Karl und Veronica Carstens-Stiftung, 1998.

(72) Concato J, Shah N, Horwitz RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 2000; 342: 1887-1892.

(73) Cook DJ, Mulrow CD, Davidoff F. Synthesis of best evidence for clinical decisions. In: Mulrow CD, Cook DJ, Hrsg. Systematic reviews - synthesis of best evidence for health care decisions. Philadelphia: ACP, 1998: 5-12.

(74) Cook DJ, Reeve BK, Guyatt GH, Griffith LF, Heyland DK, Tryba N. Stress ulcer prophylaxis in the critically ill: resolving discordant meta-analyses. JAMA 1996; 275: 308-314.

(75) Cortelli P, Sacquegna T, Albani F et al. Propranolol plasma levels and relief of migraine. Arch Neurol 1985; 42: 46-48.

(76) Cucherat M, Haugh MC, Gooch M, Biossel JP. Evidence of clinical efficacy of homeopathy. A meta-analysis of clinical trials. Eur J Clin Pharmacol 2000; 56: 27-33.

(77) Cutarella R, Santini S, Giusti A, Colangelo U. Prophylaxis of migraine without aura: Preliminary data with lysuride and flunarizine. Riv Neurobiol 1995; 41: 741-743.

(78) Dahlöf C. No clearcut longterm prophylactic effect of one month treatment with propranolol in migraineurs. Cephalalgia 1987; 7(suppl 6): 459-460.


[Seite 165↓]

(79) de-Bock GH, Eelhart J, van-Marwijk HW, Tromp TP, Springer MP. A postmarketing study of flunarizine in migraine and vertigo. Pharm World Sci 1997; 19: 269-274.

(80) Diamond S, Freitag FG. A double blind trial of flunarizine in migraine prophylaxis. Headache Quaterly 1993; 4: 169-172.

(81) Diamond S, Kudrow L, Stevens J, Shapiro DB. Long-term study of propranolol in the treatment of migraine. Headache 1982; 22: 268-271.

(82) Diamond S, Medina JL. Double blind study of propranolol for migraine prophylaxis. Headache 1976; 16: 24-27.

(83) Diamond S, Solomon GD, Freitag FG, Mehta ND. Long-acting propranolol in the prophylaxis of migraine. Headache 1987; 27: 70-72.

(84) Diehl DL. Acupuncture for gastrointestinal and hepatobiliary disorders. J Alt Complement Med 1999; 5: 27-45.

(85) Diehm C. The role of oedema protective drugs in the treatment of chronic venous insufficiency: a review of evidence based on placebo-controlled clinical trials with regard to efficacy and tolerance. Phlebology 1996; 11: 23-29.

(86) Diener HC. Efficacy and tolerability of flunarizine and propranolol in the prophylactic treatment of migraine. Cephalalgia 1999; 19: 374.

(87) Diener HC, Brune K, Gerber WD, Göbel H, Pfaffenrath V. Behandlung der Migräneattacke und Migräneprophylaxe. Deutsches Ärzteblatt 1997; 94: C-2277-C-2283.

(88) Diener HC, Foh M, Iaccarino C et al. Cyclandelate in the prophylaxis of migraine: a randomized, parallel, double-blind study in comparison with placebo and propranolol. Cephalalgia 1996; 16: 441-447.

(89) Diener HC, Hartung E, Chrubasik J et al. A comparative study of oral acetylslicyclic acid and metoprolol for the prophylactic treatment of migraine. A randomized, controlled, double-blind, parallel group phase III study. Cephalalgia 2001; 21: 120-128.

(90) Diener HC, Scholz E, Dichgans J et al. Central effects of drugs used in migraine prophylaxis evaluated by visual evoked potentials. Ann Neurol 1989; 25: 125-130.

(91) Dittmer TLJ. Die Behandlung von psychovegetativen Störungen mit Johanniskraut-Öl (Jukunda-Rot-Öl-Kapseln). Naturheilpraxis mit Naturmedizin 1992; 45: 118-122.


[Seite 166↓]

(92) Ditzler K, Schatton W. Johanniskraut bei leichten bis mittelschweren Depressionen - Ergebnisse einer plazebo-kontrollierten Doppelblindstudie. Heilkunst 1992; 104: 263-270.

(93) Dobie RA. A review of randomized clinical trials in tinnitus. Laryngoscope 1999; 109: 1202-1211.

(94) Doerr PH, Wittchen HU. Ein muskel- und gefäßorientiertes Entspannungsprogramm (SEP) zur Behandlung chronischer Migränepatienten. Eine randomisierte klinische Vergleichsstudie. Z Psychosom Med Psychoanal 1985; 31: 247-266.

(95) Dowson DI, Lewith GT, Machin D. The effects of acupuncture versus placebo in the treatment of headache. Pain 1985; 21: 35-42.

(96) Drew S, Davies E. Effectiveness of Ginkgo biloba in treating tinnitus: double blind, placebo controlled trial. BMJ 2001; 322: 1249-1252.

(97) Drillisch C, Girke W. Ergebnisse der Behandlung von Migräne-Patienten mit Cinnarizin und Flunarizin. Med Welt 1980; 31: 1870-1872.

(98) Dumont L, Mardirosoff C, Tramér M. Efficacy and harm of pharmacological prevention of acute mountain sickness: a qunatitative systematic review. BMJ 2000; 321: 267-272.

(99) Egger M, Dickersin K, Smith GD. Problems and limitations in conducting systematic reviews. In: Egger M, Smith GD, Altman DG, Hrsg. Systematic reviews in health care: meta-analysis in context. London: BMJ Books, 2001: 43-68.

(100) Egger M, Smith GD. Potentials and promise. BMJ 1997; 315: 1371-1374.

(101) Egger M, Smith GD. Bias in location and selection of studies. BMJ 1998; 316: 61-66.

(102) Egger M, Smith GD. Principles of and procedures for systematic reviews. In: Egger M, Smith GD, Hrsg. Systematic reviews in health care: meta-analysis in context. London: BMJ Publishing Group, 2001: 32-42.

(103) Emerson JD, Burdick E, Hoaglin DC, Mosteller F, Chalmers TC. An empirical study of the possible relation of treatment differences to quality scores in controlled randomized clinical trials. Contr Clin Trials 1990; 11: 339-352.

(104) Ernst E. St. John's Wort, an anti-depressant? A systematic, criteria-based review. Phytomedicine 1995; 2: 67-71.

(105) Ernst E. Acupressure for nausea: a best evidence analysis. J Phys Med Res 1996; 6: 26.


[Seite 167↓]

(106) Ernst E. Ginkgo biloba in der Behandlung der Claudicatio intermittens. Fortschr Med 1996; 114: 85-87.

(107) Ernst E. Acupuncture as a symptomatic treatment of osteoarthritis. A systematic review. Scand J Rheumatol 1997; 26: 444-447.

(108) Ernst E. Acupuncture/acupressure for weight reduction? Wien klin Wschr 1997; 109: 60-62.

(109) Ernst E. Can allium vegetables prevent cancer? Phytomedicine 1997; 4: 79-83.

(110) Ernst E. Are highly dilute homoeopathic remedies placebos? Perfusion 1998; 11: 291-292.

(111) Ernst E. Classical homoeopathy versus conventional treatment: a systematic review. Perfusion 1999; 12: 13-15.

(112) Ernst E. Homeopathic prophylaxis of headaches and migraine? A systematic review. J Pain Symptom Manag 1999; 18: 353-357.

(113) Ernst E. Second thoughts about safety of St John's wort. Lancet 1999; 354: 2014-2015.

(114) Ernst E. Plants with hypoglycaemic activity in humans. Phytomedicine 2001; 4: 73-78.

(115) Ernst E. The efficacy of Phytodolor for the treatment of musculoskeletal pain - a systematic review of randomised trials. Natural Medicine Journal 2001 (Summer): 14-17.

(116) Ernst E, Barnes J. Are homoeopathic remedies effective for delayed-onset muscle soreness? A systematic review of placebo-controlled trials. Perfusion 1998; 11: 4-8.

(117) Ernst E, Chrubasik S. Phyto-anti-inflammatories. A systematic review of randomized, placebo-controlled, double-blind trials. In: Panush RS, Hrsg. Rheumatic Disease Clinics of North America. Complementary and alternative therapies for rheumatic diseases II. Orlando: W.B. Saunders Company, 2000: 13-27.

(118) Ernst E, Huntley A. Tea trea oil: a systematic review of randomised clinical trials. Forsch Komplementärmed 2000; 7: 17-20.

(119) Ernst E, Pittler MH. Efficacy of homeopathic arnica. A systematic review of placebo-controlled clinical trials. Arch Surg 1998; 133: 1187-1190.

(120) Ernst E, Pittler MH. The effectiveness of acupuncture in treating acute dental pain: a systematic review. Br Dent J 1998; 184: 443-447.


[Seite 168↓]

(121) Ernst E, Pittler MH. Yohimbine for erectile dysfunction: a systematic review and meta-analysis of randomized clinical trials. J Urol 1998; 159: 433-436.

(122) Ernst E, Pittler MH. Ginkgo biloba for demetia: a systematic review of double-blind, placebo-controlled trials. Clin Drug Invest 1999; 17: 301-308.

(123) Ernst E, Pittler MH. Efficacy of ginger for nausea and vomiting: a systematic review of randomized clinical trials. Br J Anaesth 2000; 84: 367-371.

(124) Ernst E, Resch KL. Clinical trials of homoeopathy: a re-analysis of a published review. Forsch Komplementärmed 1996; 3: 85-90.

(125) Ernst E, Stevinson C. Ginkgo biloba for tinnitus: a review. Clin Otolaryngol 1999; 24: 164-167.

(126) Ernst E, White AR. Acupuncture as an adjuvant therapy in stroke rehabilitation. Wien med Wschr 1996; 146: 556-558.

(127) Ernst E, White AR. Acupuncture for back pain. A meta-analysis of randomized controlled trials. Arch Intern Med 1998; 158: 2235-2241.

(128) Ernst E, White AR. Acupuncture as a treatment for temporomandibular joint dysfunction. A systematic review of randomised trials. Arch Otolaryngol Head Neck Surg 2001; 125: 269-272.

(129) Evans JR. Ginkgo biloba extract for age-related macular degeneration (Cochrane Review). The Cochrane Library, issue 1, 2000. Oxford: Update Software.

(130) Eysenck HJ. Meta-analysis and its problems. BMJ 1994; 309: 789-792.

(131) Ezzo J, Berman B, Hadhazy VA, Jadad AR, Lao L, Singh BB. Is acupuncture effective for the treatment of chronic pain? A systematic review. Pain 2000; 86: 217-225.

(132) Feinstein AR. Meta-analysis: Statistical alchemy for the 21st century. J Clin Epidemiol 1995; 48: 71-79.

(133) Fischer MV, Behr A, vonReumont J. Acupuncture - a therapeutic concept in the treatment of painful conditions and functional disorders. Report on 971 cases. Acupunct Electrother Res Int J 1984; 9: 11-29.

(134) Formisano R, Falaschi P, Cerbo R et al. Nimodipine in migraine: clinical efficacy and endocrinological effects. Eur J Clin Pharmacol 1991; 41: 69-71.

(135) Forssman B, Henriksson KG, Johannsson V et al. Propranolol for migraine prophylaxis. Headache 1976; 16: 238-245.


[Seite 169↓]

(136) Freitag FG, Diamond S, Diamond M. A placebo controlled trial of flunarizine in migraine prophylaxis. Cephalalgia 1991; 11 (suppl 11): 157-158.

(137) Frenken CW, Nuijten ST. Flunarizin - ein neues Mittel zur Migräneprophylaxe. Ergebnisse eines Doppelblindvergleichs mit Plazebo. Fortschr Med 1984; 102: 349-351.

(138) Frenken CW, Nuijten ST. Flunarizine, a new preventive approach to migraine. A double-blind comparison with placebo. Clin Neurol Neurosurg 1984; 86: 17-20.

(139) Friede M, Wüstenberg P. Johanniskraut zur Therapie von Angstsyndromen bei depressiven Verstimmungen. Ztschr Phytother 1998; 19: 309-317.

(140) Fuller GN, Guiloff RJ. Propranolol in acute migraine: a controlled study. Cephalalgia 1990; 10: 229-233.

(141) Furukawa TA, Streiner DL, Hori S. Discrepancies among megatrials. J Clin Epidemiol 2000; 53: 1193-1199.

(142) Gaster B, Holroyd J. St John's wort for depression. A systematic review. Arch Intern Med 2000; 160: 152-156.

(143) Gawel M, Kreeft J, Nelson R, Simard D. Flunarizine is comparable to propranolol in the prophylaxis of migraine with and without aura. Cephalalgia 1991; 11 (suppl 11): 156.

(144) Gawel MJ, Kreeft J, Nelson RF, Simard D, Arnott WS. Comparison of the efficacy and safety of flunarizine to propranolol in the prophylaxis of migraine. Can J Neurol Sci 1992; 19: 340-345.

(145) Gerber WD, Diener HC, Kropp P, Niederberger U, Scholz E. The efficacy of flunarizine and etilefrinepivalate in migraine: An empirical double-blind and placebo-controlled study. Cephalalgia 1989; 9 (suppl 10): 450-451.

(146) Gerber WD, Diener HC, Scholz E, Niederberger U. Responders and non-responders to metoprolol, propranolol and nifedipine treatment in migraine prophylaxis: a dose-range study based on time-series analysis. Cephalalgia 1991; 11: 37-45.

(147) Gerber WD, Schellenberg R, Thom M et al. Cyclandelate versus propranolol in the prophylaxis of migraine--a double-blind placebo-controlled study. Funct Neurol 1995; 10: 27-35.

(148) Giles JT, Palat CT, Chien SH, Chang ZG, Kennedy DT. Evaluation of Echinacea for treatment of the common cold. Pharmacotherapy 2000; 20: 690-697.


[Seite 170↓]

(149) Glanville J, Lefebvre C. Wichtige Quellen für systematische Reviews. Evidence-Based Medicine, Dt Ausgabe 2000; 4: 100-101.

(150) Göbel H, Petersen-Braun M, Soyka D. Die Prävalenz von Kopfschmerzen in Deutschland. Der Schmerz 1993; 7: 287-297.

(151) Gray GE, Gray RN, McCrory D, Penzien D, Rains J, Hasselblad V. Behavioral and physical treatments for migraine headache. http://www.clinpol.mc.duke.edu . 1999.

(152) Greenland S. Quality scores are useless and potentially misleading - reply to "Re: A critical look at some popular analytic methods". Am J Epidemiol 1994; 140: 300-301.

(153) Grotemeyer KH, Husstedt IW, Schlake HP. Betablocker vs Placebo bei vasomotorischem Kopfschmerz. Eine doppelblinde Cross-over-Studie. Dtsch Med Wochenschr 1987; 112: 1740-1743.

(154) Grotemeyer KH, Scharafinski HW, Schlake HP, Husstedt IW. Acetylsalicylic acid vs. metoprolol in migraine prophylaxis--a double-blind cross-over study. Headache 1990; 30: 639-641.

(155) Grotemeyer KH, Schlake HP, Husstedt IW. Migräneprophylaxe mit Metoprolol und Flunarizin. Eine Doppelblind-cross-over-Studie. Nervenarzt 1988; 59: 549-552.

(156) Grotemeyer KH, Schlake HP, Husstedt IW. Etilefrine pivalate vs. dihydroergotamine and flunarizine in prophylactic treatment of migraine in patients with low blood pressure - a randomized double-blind study. Cephalalgia 1989; 10 (suppl 10): 433-434.

(157) Grotemeyer KH, Schlake HP, Husstedt IW, Roncolato M. Metoprolol versus flunarizine - a double-blind cross-over study. Cephalalgia 1987; 7 (suppl 6): 465-466.

(158) Guccione G, Gentile F, Pullara C, Sparacia B, Liguori A, Sparacia A. Trattamento dell'emicrania senza aura con agopuntura basata sulla differenziazione delle sindromi vs terapia farmacologica e agopuntura standadizzata. In: Gruppo Italiano di ricerca in agopuntura, Hrsg. La ricerca in agopuntura in Italia. Roma: Edizioni Paracelso, 1996: 175-177.

(159) Halama P. Wirksamkeit des Hypericum-Extraktes LI 160 bei 50 Patienten einer psychiatrischen Fachpraxis. Nervenheilkunde 1991; 10: 305-307.

(160) Halama P. Wirksamkeit des Johanniskrautextraktes LI 160 bei depressiver Verstimmung. Nervenheilkunde 1991; 10: 250-253.


[Seite 171↓]

(161) Hammerschlag R, Morris MM. Clinical trials comparing acupuncture with biomedical standard care: a criteria-based evaluation of research design and reporting. Compl Ther Med 1997; 5: 133-140.

(162) Hansen E, Hansen JH. Acupuncture treatment of chronic tensio headache - a controlled cross-over trial. Cephalalgia 1985; 5: 137-142.

(163) Hansen K, Sorensen P, Olesen J. A controlled study of flunarizine in migraine. Acta Neurol Scand 1984; 69 (suppl 98): 266-267.

(164) Harrer G, Hübner WD, Podzuweit H. Wirksamkeit und Verträglichkeit des Hypericum-Präparates LI 160 im Vergleich mit Maprotilin. Nervenheilkunde 1993; 12: 297-301.

(165) Harrer G, Hübner WD, Podzuweit H. Effectiveness and tolerance of the hypericum extract LI 160 compared to maprotiline: a multi-center double-blind study. J Geriatr Psychiatry Neurol 1994; 7 (suppl 1): S24-S28.

(166) Harrer G, Schmidt U, Kuhn U. "Alternative" Depressionsbehandlung mit einem Hypericum-Extrakt. TW Neurologie 1991; 5: 710-716.

(167) Harrer G, Schmidt U, Kuhn U, Biller A. Comparison of equivalence between the St. John's wort extract LoHyp-57 and fluoxetine. Arzneimittelforsch/Drug Res 1999; 49: 289-296.

(168) Harrer G, Sommer H. Therapie leichter/mittelschwerer Depressionen mit Hypericum. Münch med Wschr 1993; 135: 305-309.

(169) Harrer G, Sommer H. Treatment of mild/moderate depressions with Hypericum. Phytomedicine 1994; 1: 3-8.

(170) Harris PE. Acupressure: a review of the literature. Compl Ther Med 1997; 5: 156-161.

(171) Haug HU, Robben H. Die Akupunktur als Objekt allgemeinmedizinischer Forschung. Ztschr Allgemeinmed 1986; 62: 607-612.

(172) Havanka-Kanniainen H, Hokkanen E, Myllylä VV. Long acting propranolol in the prophylaxis of migraine. Comparison of the daily doses of 80 mg and 160 mg. Cephalalgia 1988; 28: 607-611.

(173) Hänsgen KD, Vesper J. Antidepressive Wirksamkeit eines hochdosierten Hypericum-Extraktes. Münch med Wschr 1996; 138: 29-33.


[Seite 172↓]

(174) Hänsgen KD, Vesper J, Ploch M. Multizentrische Doppelblindstudie zur antidepressiven Wirksamkeit des Hypericumextraktes LI 160. Nervenheilkunde 1993; 12: 285-289.

(175) Häring B, Hauns B, Hermann C, Hübner WD, Maier-Lenz H, Marschner N. A double-blind, placebo-controlled pilot study of LI 160 in combination with chemotherapy in patients with solid tumors. Abstracts 2nd International Congress on Phytomedicine. München: 1996: SL-88.

(176) Hedges LV, Olkin I. Statistical methods for meta-analysis. San Diego: Academic Press, 1985.

(177) Hedman C, Andersen AR, Andersson PG et al. Symptoms of classic migraine attacks: modifications brought about by metoprolol. Cephalalgia 1988; 8: 279-284.

(178) Hedman C, Winther K, Knudsen JB. The difference between non-selective and beta 1-selective beta-blockers in their effect on platelet function in migraine patients. Acta Neurol Scand 1986; 74: 475-478.

(179) Henry P, Baille H, Dartigues F, Jogeix M . Traitement de la maladie par acupuncture: étude controlée. Proceedings Premières rencontres Médecines Alternatives, Bordeaux, 12./13.April 1986, S. 209-216.

(180) Herberg KW. Alternative zu synthetischen Psychopharmaka? Therapiewoche 1994; 44: 704-713.

(181) Hesse J, Mogelvang B, Simonsen H. Acupuncture versus metoprolol in migraine prophylaxis: a randomized trial of trigger point inactivation. J Intern Med 1994; 235: 451-456.

(182) Heydenreich A. Die punktförmige transkutane elektrische Nervenstimulation bei funktionellen vertebragenen Störungen und bei der Migräne. Ztschr ges Inn Med 1988; 43: 651-653.

(183) Heydenreich A. Die punktförmige transkutane elektrische Nervenstimulation in der Migränetherapie. Psychiat Neurol med Psychol 1988; 40: 717-723.

(184) Heydenreich A. Punktförmige transkutane elektrische Nervenstimulation (PuTENS) im einfachen Placebovergleich bei der Migräne. (Eine prospektive randomisierte Studie). Ztschr ärztl Fortbild 1989; 83: 881-883.

(185) Hill C, Doyon F. Review of randomized trials of homoeopathy. Rev Epidem Santé Publ 1990; 38: 139-147.


[Seite 173↓]

(186) Hoffmann J, Kühl ED. Therapie von depressiven Zuständen mit Hypericin. Z Allgemeinmed 1979; 55: 776-782.

(187) Holdorff B, Sinn M, Roth G. Propranolol in der Migräneprophylaxe. Eine Doppelblindstudie. Med Klin 1977; 72: 1115-1118.

(188) Holroyd KA, France JL, Cordingley GE et al. Enhancing the effectiveness of relaxation-thermal biofeedback training with propranolol hydrochloride. J Consult Clin Psychol 1995; 63: 327-330.

(189) Holroyd KA, Penzien D. Propranolol in the management of recurrent migraine: a meta-analytic review. Headache 1991; 31: 333-340.

(190) Hopayian K. The need for caution in interpreting high quality systematic reviews. BMJ 2001; 323: 681-684.

(191) Hopfenmüller W. Nachweis der therapeutischen Wirksamkeit eines Ginkgo biloba-Spezialextraktes - Meta-Analyse von 11 klinischen Studien mit Patienten mit Hirnleistungsstörungen im Alter. Arzneim-Forsch/Drug Res 1994; 44(II), 1005-1013.

(192) Hotopf M. Review: St John's wort is more effective than placebo for treating depressive disorders. Evidence-Based Mental Health 1999; 2: 49.

(193) Hottenrott K, Sommer HM, Lehrl S, Hauer H. Der Einfluss von Vitamin E und Johanniskraut-Trockenextrakt auf die Ausdauerleistungsfähigkeit von Wettkampfsportlern. Eine placebo-kontrollierte Doppelblindstudie mit Langstreckenläufern und Triathleten. Dtsche Ztschr Sportmed 1997; 48: 22-27.

(194) Hu HH, Cung C, Liu TJ et al. A randomized controlled trial on the treatment for acute partial ischemic stroke with acupuncture. Neuroepidemiol 1993; 12: 106-113.

(195) Hübner WD, Lande S, Podzuweit H. Behandlung larvierter Depressionen mit Johanniskraut. Nervenheilkunde 1993; 12: 278-280.

(196) Hübner WD, Lande S, Podzuweit H. Hypericum treatment of mild depression with somatic symptoms. J Geriatr Psychiatry Neurol 1994; 7 (suppl. 1): S12-S15.

(197) International Headache Society Committee on Clinical Trials in Migraine. Guideline for controlled trials of drugs in migraine. First edition. Cephalalgia 1991; 11: 1-12.

(198) International Headache Society Clinical Trials Subcommittee. Guideline for controlled trials of drugs in migraine: second edition. Cephalalgia 2000; 20: 765-786.


[Seite 174↓]

(199) Ioannidis JPA, Haidich AB, Pappa M et al. Comparison of evidence of treatment effects in randomized and nonrandomized studies. JAMA 2001; 286: 821-830.

(200) Jacobs JWG, Rasker JJ, vanRiel PLCM, Griebnau FWJ, vandePutte LBA. Alternatieve behandelingswijzen bij reumatische aandoeningen; een literatuuronderzoek. Ned Tijdschr Geneeskd 1991; 135: 317-322.

(201) Jadad AR, Booker L, Gauld M et al. The treatment of attention-deficit hyperactivity disorder: an annotated bibliography and critical appraisal of published systematic reviews and metaanalyses. Can J Psychiatr 1999; 44: 1025-1035.

(202) Jadad AR, Cook DJ, Browman GP. A guide to interpret discordant systematic reviews. CMAJ 1997; 156: 1411-1416.

(203) Jadad AR, Cook DJ, Jones A et al. Methodology and reports of systematic reviews and meta-analyses. A comparison of Cochrane reviews with articles published in paper-based journals. JAMA 1998; 280: 278-280.

(204) Jadad AR, McQuay HJ. Meta-Analyses to evaluate analgesic interventions: a systematic qualitative review of their methodology. J Clin Epidemiol 1996; 49: 235-243.

(205) Jadad AR, Moher M, Browman GP et al. Systematic reviews and meta-analyses on treatment of asthma - a critical evaluation. BMJ 2000; 320: 537-540.

(206) Jadad AR, Moore RA, Carroll D et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Contr Clin Trials 1996; 17: 1-12.

(207) Jailwala J, Imperiale TF, Kroenke K. Pharmacologic treatment of the irritable bowel syndrome: a systematic review of randomized, controlled trials. Ann Intern Med 2000; 133: 136-147.

(208) Jensen LB, Jensen SB. Effect of acupuncture on tension headache and urinary catecholamine excretion. Scand J Dent Res 1982; 90: 69-75.

(209) Jensen LB, Melsen B, Jensen SB. Effect of acupuncture on headache measured by reduction in number of attacks and use of drugs. Scand J Dent Res 1979; 87: 373-380.

(210) Jensen LB, Tallgren A, Troest T, Jensen SB. Effect of acupuncture on myogenic headache. Scand J Dent Res 1977; 85: 456-470.

(211) Jepson RG, Kleijnen J, Leng GC. Garlic for lower limb atherosclerosis (Cochrane Review). The Cochrane Library, issue 2, 1997. Oxford: Update Software


[Seite 175↓]

(212) Jepson RG, Mihaljevic L, Craig J. Cranberries for the treatment of urinary tract infection (Cochrane Review). The Cochrane Library, issue 4, 1998. Oxford: Update Software.

(213) Jepson RG, Mihaljevic L, Craig J. Cranberries for preventing urinary tract infections (Cochrane Review). The Cochrane Library, issue 1, 2001. Oxford: Update Software.

(214) Jewell D, Young G. Interventions for nausea and vomiting in early pregnancy (Cochrane Review). The Cochrane Library, issue 4, 1998. Oxford: Update Software.

(215) Johansson V, Kosic S, Lindahl O, Lindwall L, Tibbling L. Effect of acupuncture in tension headache and brainstem reflexes. Advances in Pain Research and Therapy 1976; 1: 839-841.

(216) Johnson D. Neurophysiologische Wirkungen von Hypericum im Doppelblindversuch mit Probanden. Nervenheilkunde 1991; 10: 316-317.

(217) Johnson D, Ksciuk H, Woelk H, Sauerwein-Giese E, Frauendorf A. Wirkungen mit Johanniskraut-Extrakt LI 160 im Vergleich mit Maprotilin auf Ruhe-EEG und evozierte Potentiale bei 24 Probanden. Nervenheilkunde 1993; 12: 328-330.

(218) Johnson RH, Hornabrook RW, Lambie DG. Comparison of mefenamic acid and propranolol with placebo in migraine prophylaxis. Acta Neurol Scand 1986; 73: 490-492.

(219) Jonas WB, Linde K, Ramirez G. Homeopathy and rheumatic disease. In: Panush RS, Hrsg. Rheumatic Disease Clinics of North America. Complementary and alternative theapies for rheumatic diseases II. Orlando: W.B. Saunders Company, 2000: 117-123.

(220) Josey ES, Tacket RL. St. John's wort: a new alternative for depression? Int J Clin Pharmacol Therap 1999; 37: 111-119.

(221) Joy CB, Mumby-Croft R, Joy LA. Polyunsaturated fatty acid (fish or evening primrose oil) for schizophrenia (Cochrane Review). The Cochrane Library, issue 2, 2000. Oxford: Update Software.

(222) Julien J, Vallat JM, Lagueny A, Darriet M. Le traitement prophylactique des migraines par le propranolol. La Nouvelle Presse Médicale 1976; 5: 653.

(223) Junnila SYT. Acupuncture for long-term treatment of headache in a national health center. Am J Acupunct 1986; 14: 351-353.

(224) Junnila SYT. Long-term treatment of chronic pain with acupuncture. Part I. Acupunct Electro-Ther Res Int J 1987; 12: 23-36.


[Seite 176↓]

(225) Jüni P, Witschi A, Bloch R, Egger M. The hazards of scoring the quality of clinical trials for meta-analysis. JAMA 1999; 282: 1054-1060.

(226) Kangasniemi P, Andersen AR, Andersson PG et al. Classic migraine: effective prophylaxis with metoprolol. Cephalalgia 1987; 7: 231-238.

(227) Kangasniemi P, Hedman C. Metoprolol and propranolol in the prophylactic treatment of classical and common migraine. A double-blind study. Cephalalgia 1984; 4: 91-96.

(228) Kangasniemi PJ, Nyrke T, Lang AH, Petersen E. Femoxetine - a new 5-HT uptake inhibitor - and propranolol in the prophylactic treatment of migraine. Acta Neurol Scand 1983; 68: 262-267.

(229) Kaniecki RG. A comparison of divalproex with propranolol and placebo for the prophylaxis of migraine without aura. Arch Neurol 1997; 54: 1141-1145.

(230) Kass B, Nestvold K. Propranolol (Inderal) and clonidine (Catapressan) in the prophylactic treatment of migraine. A comparative trial. Acta Neurol Scand 1980; 61: 351-356.

(231) Katerndahl DA, Lawler WR. Variability in meta-analytic resutls concerning the value of cholesterol reduction in coronary heart disease: a meta-analysis. Am J Epidemiol 1999; 149: 429-441.

(232) Kendrick T. Prescribing antidepressants in general practice. BMJ 1996; 313: 829-830.

(233) Kiene H. Klinische Studien zur Misteltherapie der Krebserkrankung. Eine kritische Würdigung. Herdecke: Dissertation, 1989.

(234) Kiene H. Klinische Studien zur Misteltherapie karzinomatöser Erkrankungen. Therapeutikon 1989; 6: 347-353.

(235) Kim HL, Streltzer J, Goebert D. St. John's wort for depression: A meta-analysis of well-defined clinical trials. J Nerv Ment Dis 1999; 187: 532-539.

(236) Kim KC, Yount RA. The effect of acupuncture on migraine headache. Am J Chin Med 1974; 2: 407-411.

(237) Kjaersgard RM, Holt LB, Borg L, Soelberg SP, Hansen PE. Tolfenamic acid versus propranolol in the prophylactic treatment of migraine. Acta Neurol Scand 1994; 89: 446-450.

(238) Klapper JA. An open label cross-over study of divalproex sodium and propranolol HCl in the prevention of migraine headaches. Headache Quaterly 1994; 5: 50-53.


[Seite 177↓]

(239) Kleijnen J. Controlled clinical trials in humans on the effects of garlic supplements. In: Kleijnen J, Hrsg. Food supplements and their efficacy. Maastricht: Rijksuniversiteit Limburg, 1991: 73-82.

(240) Kleijnen J, Knipschild P. Ginkgo biloba for intermittent claudication and cerebral insufficiency. In: Klejnen J, Hrsg. Food supplements and their efficacy. Maastricht: Rijksuniversiteit Limburg, 1991: 83-94.

(241) Kleijnen J, Knipschild P. Gingko biloba for cerebral insufficiency. Br J clin Pharm 1992; 34: 352-358.

(242) Kleijnen J, Knipschild P. Review article and publication bias. Arzneim-Forsch/Drug Res 1992; 42(I): 587-591.

(243) Kleijnen J, Knipschild P. Mistletoe treatment for cancer. Review of controlled trials in humans. Phytomedicine 1994; 1: 255-260.

(244) Kleijnen J, Knipschild P, ter Riet G. Garlic, onions and cardiovascular risk factors. A review of the evidence from human experiments with emphasis on commercially available preparations. Br J clin Pharm 1989; 28: 535-544.

(245) Kleijnen J, Knipschild P, ter Riet G. Clinical trials of homoeopathy. BMJ 1991; 302: 316-323.

(246) Kleijnen J, ter Riet G, Knipschild P. Acupuncture and asthma: a review of controlled trials. Thorax 1991; 46: 799-802.

(247) Kleijnen J, ter Riet G, Knipschild P. Evening primrose oil. In: Kleijnen J, Hrsg. Food supplements and their efficacy. Maastricht: Rijksuniveriteit Limburg, 1991: 51-61.

(248) Kniebel R, Burchard JM. Zur Therapie depressiver Verstimmungen in der Praxis. Z Allgemeinmed 1988; 64: 689-696.

(249) Knipschild P. Ginseng: pep of nep nep? Pharmaceutisch Weekblad 1988; 123: 4-11.

(250) König CD. Hypericum perforatum L. (gemeines Johanniskraut) als Therapeutikum bei depressiven Verstimmungszuständen - eine Altermative zu synthetischen Arzneimitteln. Dissertation, Universität Basel, 1993.

(251) Kubiena G. Akupunktur bei Migräne - eine Dreijahresstudie mit den Migränepatient(inn)en der Ambulanz des Ludwig-Boltzmann-Institutes für Akupunktur in Wien 1976-1978. Dtsche Ztschr Akup 1985; 28: 4-14.


[Seite 178↓]

(252) Kubiena G, Nissel H, Porenta G, Veitl M, Wessely P. Akupunktur bei Migräne. Follow-up Studie. Dtsche Ztschr Akup 1992; 35: 140-148.

(253) Kugler J, Schmidt A, Groll S, Weidenhammer W. Zur Pharmakodynamik eines Hypericum-Extraktes. Untersuchungen bei Patienten mit depressiven Zuständen im Vergleich zu Bromazepam und Placebo. Z Allgemeinmed 1990; 66: 13-20.

(254) Kugler J, Weidenhammer W, Schmidt A, Groll S. Therapie depressiver Zustände. Z Allgemeinmed 1990; 66: 21-29.

(255) Kunz R, Fritsche L, Neumayer HH. Kritische Bewertung von präventiven oder therapeutischen Interventionen. In: Kunz R, Ollenschläger G, Raspe H, Jonitz G, Kolkmann FW, Hrsg. Lehrbuch evidenzbasierte Medizin in Klinik und Praxis. Köln: Deutscher Ärzte Verlag, 2000: 120-135.

(256) Kunz R, Oxman AD. The unpredictability paradox: review of empirical comparisons of randomised and non-randomised clinical trials. BMJ 1998; 317: 1185-1190.

(257) Kuritzky A, Hering R. Prophylactic treatment of migraine with long acting propranolol - a comparison with placebo. Cephalalgia 1987; 7 (suppl 6): 457-458.

(258) Laakmann G, Dienel A, Kieser M. Clinical significance of hyperforin for the efficacy of Hypericum extracts on depressive disorders of different severities. Phytomedicine 1998; 5: 435-442.

(259) Laakmann G, Schüle C, Baghai T, Kieser M. St. John's Wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy. Pharmacopsychiatry 1998; 31: 54-59.

(260) Laitinen J. Acupuncture for migraine prophylaxis: a prospective clinical study with six month's follow-up. Am J Chin Med 1975; 3: 271-274.

(261) Lamsudin R, Sadjimin T. Comparison of the efficacy between flunarizine and nifedipine in the prophylaxis of migraine. Headache 1993; 33: 335-338.

(262) Langohr HD, Gerber WD, Koletzki E, Mayer K, Schroth G. Clomipramine and metoprolol in migraine prophylaxis--a double-blind crossover study. Headache 1985; 25: 107-113.

(263) Langohr HD, Reinecke M, Gerber WD, Mangold R. Dihydroergotamin und Flunarizin in der Migräne-Prophylaxe. Eine vergleichende Doppelblind-Studie. Fortschr Med 1988; 106: 65-70.


[Seite 179↓]

(264) Lastilla M, Achille P, Savarese MA, Frascella G. Verapamil versus flunarizina nella terapia preventiva dell'emicrania. Clin Ter 1990; 132: 401-404.

(265) Lautenschlager J. Akupunktur bei der Behandlung entzündlich-rheumatischer Erkrankungen. Ztschr Rheumatol 1997; 56: 8-20.

(266) Law M, Tang JL. An analysis of the effectiveness of interventions intended to help people stop smoking. Arch Intern Med 1995; 155: 1933-1941.

(267) Lawrence RM. Acupuncture for the treatment of headache. Am J Acupunct 1974; 2: 105-109.

(268) Lawrence V, Mulrow C, Ackerman R et al. Garlic: effects on cardiovascular risks and disease, protective effects against cancer, and clinical adverse effects. Evidence Report/Technology Assessment 20. Agency for Healthcare Research and Quality, Rockville, MD, 2000.

(269) Lawrence V, Mulrow C, Jacobs B et al. Report on milk thistle: Effects on liver disease and cirrhosis amd clinical adverse effects. Evidence Report/Technology Assessment 21. Agency for Healthcare Research and Quality, Rockville, MD, 2000.

(270) Lee A, Done ML. The use of nonpharmacologic techniques to prevent postoperative nausea and vomiting: a meta-analysis. Anesth Analg 1999; 88: 1362-1369.

(271) Lefebvre C, Clarke MJ. Identifying randomised trials. In: Egger M, Smith GD, Altman D, Hrsg. Systematic reviews in health care: meta-analysis in context. London: BMJ Publishing Group, 2001: 69-86.

(272) Lehmann V, Banzhaf E, Kunze E et al. Randomisierte klinisch kontrollierte Studie der Effizienz der Akupunktur im Vergleich zur Elektroakupunktur sowie zur Pharmakotherapie mit Propranolol bei Patienten mit häufiger Migräne. Dtsche Ztschr Akup 1991; 34: 27-30.

(273) Lehrl S, Woelk H. Ergebnisse von Messungen der kognitiven Leistungsfähigkeit bei Patienten unter der Therapie mit Johanniskraut. Nervenheilkunde 1993; 12: 281-284.

(274) LeLorier J, Gregoire G, Benhaddad A, Lappierre J, Derderian F. Discrepancies between meta-analyses and subsequent large randomized, controlled trials. N Engl J Med 1997; 337: 536-542.

(275) Lenhard L, Waite PM. Acupuncture in the prophylactic treatment of migraine headaches: pilot study. N Z Med J 1983; 96: 663-666.


[Seite 180↓]

(276) Lenoir S, Degenring FH, Saller R. A double-blind randomised trial to investigate three different concentrations of a standardised fresh plant extract obtained from the shoot tips of Hypericum perforatum L. Phytomedicine 1999; 6: 141-146.

(277) Letzel H, Schoop W. Gingko-biloba-Extrakt EGb 761 und Pentoxifyllin bei Claudicatio intermittens. Sekundäranalyse zur klinischen Wirksamkeit. VASA 1992; 21: 403-410.

(278) Linde K, Clausius N, Ramirez G et al. Are the clinical effects of homoeopathy placebo effects? A meta-analysis of placebo-controlled trials. Lancet 1997; 350: 834-843.

(279) Linde K, Hondras M, Vickers A, ter Riet G, Melchart D. Systematic reviews of complementary therapies - an annotated bibliography. Part 3: Homeopathy. BMC Complement Alt Med 2001; 1: 4. (verfügbar unter www.biomedcentral.com)

(280) Linde K, Jobst K, Panton J. Acupuncture for the treatment of asthma bronchiale (Cochrane Review). The Cochrane Library, issue 1, 1997. Oxford: Update Software.

(281) Linde K, Jobst KA. Homeopathy for chronic asthma (Cochrane Review). The Cochrane Library, issue 1, 1998. Oxford: Update Software.

(282) Linde K, Jonas WB, Melchart D, Willich S. The methodological quality of randomized controlled trials of homeopathy, herbal medicines and acupuncture. Int J Epidemiol 2001; 30: 526-531.

(283) Linde K, Melchart D. Randomized controlled trials of individualized homeopathy: a state-of-the-art review. J Alt Complement Med 1998; 4: 371-388.

(284) Linde K, Melchart D, Willich S. Beschreibung der Therapie in klinischen Studien zur Akupunktur bei chronischen Kopfschmerzen. Dtsche Ztschr Akup 2001; 44: 8-14.

(285) Linde K, Mulrow CD. St John's wort for depression (Cochrane Review). The Cochrane Library, issue 3, 1998. Oxford: Update Software.

(286) Linde K, Ramirez G, Mulrow CD, Pauls A, Weidenhammer W, Melchart D. St John's wort for depression - an overview and meta-analysis of randomised clinical trials. BMJ 1996; 313: 253-258.

(287) Linde K, Scholz M, Ramirez G, Clausius N, Melchart D, Jonas WB. Impact of study quality on outcome in placebo-controlled trials of homeopathy. J Clin Epidemiol 1999; 52: 631-636.

(288) Linde K, ter Riet G, Hondras M, Vickers A, Saller R, Melchart D. Systematic reviews of complementary therapies - an annotated bibliography. Part 2: Herbal medicine. BMC Complement Alt Med 2001; 1: 5. (verfügbar unter www.biomedcentral.com)


[Seite 181↓]

(289) Linde K, Vickers A, Hondras M et al. Systematic reviews of complementary therapies - an annotated bibliography. Part I: Acupuncture. BMC Complement Alt Med 2001; 1: 3. (verfügbar unter www.biomedcentral.com)

(290) Linde K, Worku F, Stör W et al. Randomized clinical trials of acupuncture for asthma - a systematic review. Forsch Komplementärmed 1996; 3: 148-155.

(291) Lipsey MW, Wilson DB. The efficacy of psychological, educational, and behavioral treatment - confirmation from meta-analysis. American Psychologist 1993; 48: 1181-1209.

(292) Loh L, Nathan PW, Schott GD, Zilkha KJ. Acupuncture versus medical treatment for migraine and muscle tension headaches. J Neurol Neurosurg Psychiatry 1984; 47: 333-337.

(293) Longworth W, McCarthy PW. A review of research on acupuncture for the treatment of lumbar disk protrusions and associated neurological symptomatology. J Alt Complement Med 1997; 3: 55-76.

(294) Louis P. A double-blind placebo-controlled prophylactic study of flunarizine (Sibelium) in migraine. Headache 1981; 21: 235-239.

(295) Louis P, Schoenen J, Hedman C. Metoprolol v. clonidine in the prophylactic treatment of migraine. Cephalalgia 1985; 5: 159-165.

(296) Louis P, Spierings EL. Comparison of flunarizine (Sibelium) and pizotifen (Sandomigran) in migraine treatment: a double-blind study. Cephalalgia 1982; 2: 197-203.

(297) Lucking CH, Oestreich W, Schmidt R, Soyka D. Flunarizine vs. propranolol in the prophylaxis of migraine: two double-blind comparative studies in more than 400 patients. Cephalalgia 1988; 8 (suppl 8): 21-26.

(298) Ludin HP. Flunarizine and propranolol in the treatment of migraine. Headache 1989; 29: 219-224.

(299) Lutz C. Quantitative Meta-Analyse empirischer Ergebnisse der Homöopathieforschung. Universität Freiburg: Diplomarbeit Psychologisches Institut, 1993.

(300) Lüdtke R, Wiesenauer M. Eine Metaanalyse der homöopathischen Behandlung der Pollinosis mit Galphimia glauca. Wien klin Wschr 1997; 147: 323-327.


[Seite 182↓]

(301) Lüdtke R, Wilkens J. Klinische Wirksamkeitsstudien zu Arnica in homöopathischen Zubereitungen. In: Albrecht H, Frühwald M, Hrsg. Karl und Veronica Carstens-Stiftung, Jahrbuch, Band 5. Essen: KVC Verlag, 1998: 97-112.

(302) MacDonald R, Ishani A, Rutks I, Wilt TJ. A systematic review of Cernilton for the treatment of benign prostata hyperplasia. Br J Urol Int 2000; 85: 836-841.

(303) Maissenbacher J, Schmidt U, Schenk N. Therapie mit Hypericum bei Angstzuständen. TW Neurol Psychiatr 1995; 9: 65-70.

(304) Maissen CP, Ludin HP. Vergleich der Wirksamkeit von 5-Hydroxytrypthophan und von Propranolol in der Intervallbehandlung der Migräne. Schweiz med Wschr 1991; 121: 1585-1590.

(305) Major P, Standnes B. Akupunkturbehandling ved migrene. Tidsskr Nor Laegeforen 1983; 103: 686-689.

(306) Malvea BP, Gwon N, Graham JR. Propranolol prophylaxis of migraine. Headache 1973; 12: 163-167.

(307) Manzoni GC, Bono G, Sacquegna T et al. Flunarizine in common migraine: Italian cooperative trial. I. Short-term results and responders' definition. Cephalalgia 1985; 5 (suppl 2): 149-153.

(308) Martinez B, Kasper S, Ruhrmann B, Möller HJ. Hypericum in der Behandlung von saisonal abhängigen Depressionen. Nervenheilkunde 1993; 12 : 302-307.

(309) Martinez LJ. Flunarizine (Sibelium) in the prophylaxis of migraine. An open, long-term, multicenter trial. Cephalalgia 1988; 8 (suppl 8): 15-20.

(310) Mathew NT. Prophylaxis of migraine and mixed headache. A randomized controlled study. Headache 1981; 21: 105-109.

(311) Maxion H, Klein HJ. Zur Pathogenese und Behandlung der Migräne. Münch med Wschr 1978; 120: 315-318.

(312) McCrory D, Penzien DB, Gray RN, Hasselblad V. Behavioral and physical treatments for tension-type and cervicogenic headache. Verfügbar unter http://www.fcer.org. 2000.

(313) McIntosh HM, Ollario P. Artemisin derivatives for treating severe malaria (Cochrane Review). The Cochrane Library, issue 2, 2000. Oxford: Update Software.


[Seite 183↓]

(314) McIntosh HM, Ollario P. Artemisin derivatives for treating uncomplicated malaria (Cochrane Review). The Cochrane Library, issue 2, 2000. Oxford: Update Software.

(315) McKibbin LS, Downie R. Treatment of migraine headaches using auricular acupuncture techniques. Laser Ther 1993; 5: 23-28.

(316) McPartland JM, Pruitt PL. Medical marijuana and its use by the immunocompromised. Alternat Ther Health Med 1997; 3: 39-45.

(317) McPherson K, Britton AR, Wennberg JE. Are randomized controlled trials controlled? Patient preferences and unblind trials. J R Soc Med 1997; 90: 652-656.

(318) Meier B. The science behind hypericum. Advances in Therapy 1999; 16: 135-147.

(319) Melchart D, Linde K, Fischer P et al. Acupuncture for idiopathic headache (Cochrane Review). The Cochrane Library, issue 1, 2001. Oxford: Update Software.

(320) Melchart D, Linde K, Fischer P, Kaesmayr J. Echinacea for prevention and treatment of the common cold (Cochrane Review). The Cochrane Library, issue 1, 1999. Oxford: Update Software.

(321) Melchart D, Linde K, Fischer P et al. Acupuncture for recurrent headaches: a systematic review of randomized controlled trials. Cephalalgia 1999; 19: 779-786.

(322) Melchart D, Linde K, Worku F, Bauer R, Wagner H. Immunomodulation with Echinacea - a systematic review of controlled clinical trials. Phytomedicine 1994; 1: 245-254.

(323) Mendenopoulos G, Manafi T, Logothetis J, Bostantzopoulou S. Flunarizine in the prevention of classical migraine: a placebo-controlled evaluation. Cephalalgia 1985; 5 (suppl 2): 135-140.

(324) Micieli G, Piazza D, Sinforiani E et al. Antimigraine drugs in the management of daily chronic headaches: clinical profiles of responsive patients. Cephalalgia 1985; 5 (suppl 2): 219-224.

(325) Mikkelsen B, Pedersen KK, Christiansen LV. Prophylactic treatment of migraine with tolfenamic acid, propranolol and placebo. Acta Neurol Scand 1986; 73: 423-427.

(326) Mitsikostas DD, Polychronidis I. Valproate versus flunarizine in migraine prophylaxis: a randomized, double-open, clinical trial. Funct Neurol 1997; 12: 267-276.


[Seite 184↓]

(327) Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Lancet 1999; 354: 1896-1900.

(328) Moher D, Fortin P, Jadad AR et al. Completeness of reporting of trials published in languages other than English: implications for conduct and reporting of systematic reviews. Lancet 1996; 347: 363-366.

(329) Moher D, Jadad AR, Nichol G, Penman M, Tugwell P, Walsh S. Assessing the quality of randomized controlled trials: an annotated bibliography of scales and checklists. Contr Clin Trials 1995; 16: 62-73.

(330) Moher D, Pham B, Ausejo M, Saenz A, Hood S, Barber GG. Pharmacological management of intermittent claudication: a meta-analysis of randomised trials. Drugs 2000; 59: 1057-1070.

(331) Moher D, Pham B, Jones A et al. Does quality of reports or randomised trials affect estimates of intervention efficacy reported in meta-analyses? Lancet 1998; 352: 609-613.

(332) Moher D, Pham B, Klassen TP et al. What contributions do languages other than English make on the results of meta-analyses? J Clin Epidemiol 2000; 53: 964-972.

(333) Moher D, Schulz KF, Altman D. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA 2001; 285: 1987-1991.

(334) Montastruc JL, Senard JM. Medicaments anticalciques et prophylaxie de la migraine. Pathol Biol Paris 1992; 40: 381-388.

(335) Montgomery SA, Hübner WD, Grigoleit HG. Efficacy and tolerability of St. John's wort extract compared with placebo in patients with a mild to moderate depressive disorder. Phytomedicine 2000; 7 (suppl II): 107.

(336) Morse PF, Horrobin DF, Manku MS et al. Meta-analysis of placebo-controlled studies of the efficacy of Epogam in the treatment of atopic eczema. Relationship between plasma essential fatty acid changes and response. Br J Dermatol 1989; 121: 75-90.

(337) Mulrow C, Lawrence V, Ackerman R. Garlic: effects on cardiovascular risks and disease, potective effects against cancer, and clinical adverse effects. Evidence Report/Technology Assessment No. 20. Rockville: Agency for Healthcare Research and Quality, 2000.


[Seite 185↓]

(338) n.n. Johanniskraut vs. SSRI - neue Erkenntnisse zur Wirksamkeit und Verträglichkeit. Nervenheilkunde 2000 (1): 92-93.

(339) Nadelmann JW, Phil M, Stevens J, Saper JR. Propranolol in the prophylaxis of migraine. Headache 1986; 26: 175-182.

(340) Nahrstedt A, Butterweck V. Biologically active and other chemical constituents of the herb of hypericum perforatum. Pharmacopsychiatry 1997; 30 (suppl 2): 129-134.

(341) Nappi G, Sandrini G, Savoini G, Cavallini A, de-Rysky C, Micieli G. Comparative efficacy of cyclandelate versus flunarizine in the prophylactic treatment of migraine. Drugs 1987; 33 (suppl 2): 103-109.

(342) Neil HAW, Silagy C, Lancaster T et al. Garlic powder in the treatment of moderate hyperlipidemia: a controlled trial and meta-analysis. J Roy Coll Pract London 1996; 30: 329-334.

(343) Nicolodi M, Del-Bianco PL, Sicuteri F. The way to serotonergic use and abuse in migraine. Int J Clin Pharmacol Res 1997; 17: 79-84.

(344) Nuijten STM. Comparative trial of flunarizine and pizotifen in the prophylaxis of migraine. J Neurol 1985; 232 (suppl): 219.

(345) Nuti A, Lucetti C, Pavese N, Dell'Agnello G, Rossi G, Bonuccelli U. Long-term follow-up after flunarizine or nimodipine discontinuation in migraine patients. Cephalalgia 1996; 16: 337-340.

(346) Nyrke T, Kangasniemi P, Lang AH, Petersen E. Steady-state visual evoked potentials during migraine prophylaxis by propranolol and femoxetine. Acta Neurol Scand 1984; 69: 9-14.

(347) Oakley-Browne M, Hatcher S, Churchill R et al. Cochrane Depression, Anxiety and Neurosis Group. The Cochrane Library, issue 4, 2001. Oxford: Update Software.

(348) Okazaki K, Sadove MS, Kim SI, Lee MH, Cheng D. Ryodoraku therapy for migraine headache. Am J Chin Med 1975; 3: 61-70.

(349) Oken BS, Storzbach DM, Kaye JA. The efficacy of Ginkgo biloba on cognitive function in Alzheimer disease. Arch Neurol 1998; 55: 1409-1415.

(350) Olerud B, Gustavsson CL, Furberg B. Nadolol and propranolol in migraine management. Headache 1986; 26: 490-493.


[Seite 186↓]

(351) Olesen J. Role of calcium entry blockers in the prophylaxis of migraine. Eur Neurol 1986; 25 (suppl 1): 72-79.

(352) Olkin I. Invited commentary: "a critical look at some popular meta-analysis methods". Am J Epidemiol 1994; 140: 297-299.

(353) Olsson JE, Behring HC, Forssman B et al. Metoprolol and propranolol in migraine prophylaxis: a double-blind multicentre study. Acta Neurol Scand 1984; 70: 160-168.

(354) Osterheider M, Schmidtke A, Beckmann H. Behandlung depressiver Syndrome mit Hypericum (Johanniskraut) - eine placebokontrollierte Doppelblindstudie. Fortschr Neurol Psychiatr 1992; 60 (suppl 2): 210-211.

(355) Oxman AD, Guyatt GH. Validitation of an index of the quality of review articles. J Clin Epidemiol 1991; 44: 1271-1278.

(356) Oxman AD, Guyatt GH, Singer J et al. Agreement among reviewers of review articles. J Clin Epidemiol 1991; 44: 91-98.

(357) Palferman TG, Gibberd FB, Simmonds JP. Prophylactic propranolol in the treatment of headache. Br J clin Pharm 1983; 37: 28-29.

(358) Panijel M. Die Behandlung mittelschwerer Angstzustände. Randomisierte Doppelblindstudie zum klinischen Wirksamkeitsvergleich eines Phytotherapeutikums mit Diazepam. Therapiewoche 1985; 41: 4659-4668.

(359) Park J, Hopwood V, White AR, Ernst E. Effectiveness of acupuncture for stroke: a systematic review. J Neurol 2001; 248: 558-563.

(360) Park J, White AR, Ernst E. Efficacy of acupuncture as a treatment for tinnitus. Arch Otolaryngol Head Neck Surg 2000; 126: 489-492.

(361) Patel MS, Gutzwiller F, Paccaud F, Marazzi A. A meta-analysis of acupuncture for chronic pain. Int J Epidemiol 1989; 18: 900-906.

(362) Paterna S, Martino SG, Campisi D, Cascio IN, Marsala BA. Valutazione degli effetti indotti dall'uso di verapamile, flunarizina, diltiazem, nimodipina e placebo nella profilassi dell'emicrania. Studio a doppio cieco randomizzato cross-over. Clin Ter 1990; 134: 119-125.

(363) Penzien D, Johnson C, Carpenter D, Holroyd Jackson K. Drug vs. behavioral treatment of migraine: Long-acting propranolol vs. home-based self-management training. Headache 190; 30: 300.


[Seite 187↓]

(364) Petitti DB. Meta-analysis, decision analysis and cost-effectiveness analysis. Oxford: Oxford University Press, 1994.

(365) Philipp M, Kohnen R, Hiller KO. Hypericum extract versus imipramine or placebo in patients with moderate depression: randomised multicentre study of treatment for eight weeks. BMJ 1999; 319: 1534-1539.

(366) Pini LA, Ferrari A, Guidetti G, Galetti G, Barbieri L, Sternieri E. Effectiveness of flunarizine in altering electronystagmographic patterns in migraine patients: a preliminary report. Int J Clin Pharmacol Res 1986; 6: 27-32.

(367) Pini LA, Ferrari A, Guidetti G, Galetti G, Sternieri E. Influence of flunarizine on the altered electronystagmographic (ENG) recordings in migraine. Cephalalgia 1985; 5 (suppl 2): 173-175.

(368) Pintov S, Lahat E, Alstein M, Vogel Z, Barg J. Acupuncture and the opioid system: implications in management of migraine. Pediatr Neurol 1997; 17: 129-133.

(369) Piscitelli S, Burstein AH, Chaitt D, Alfaro RM, Falloon J. Indinavir concentrations and St John's wort. Lancet 2000; 355: 547-548.

(370) Pita E, Higueras A, Bolanos J, Perez N, Mundo A. Propranolol and migraine. A clinical trial. Arch Farmacol Toxicol 1977; 3: 273-278.

(371) Pittler MH, Ernst E. Artichoke leaf extract for serum cholesterol reduction. Perfusion 1998; 11: 338-340.

(372) Pittler MH, Ernst E. Horse-chestnut seed extract for chronic venous insufficiency. A criteria-based systematic review. Arch Dermatol 1998; 134: 1356-1360.

(373) Pittler MH, Ernst E. Peppermint oil for irritable bowel syndrome: a critical review and metaanalysis. Am J Gastroenterol 1998; 93: 1131-1135.

(374) Pittler MH, Ernst E. Artemether for severe malaria: a meta-analysis of randomized clinical trials. Clin Infect Dis 1999; 28: 597-601.

(375) Pittler MH, Ernst E. Efficacy of kava extract for treating anxiety: systematic review and meta-analysis. J Clin Psychopharmacol 2000; 20: 84-89.

(376) Pittler MH, Ernst E. Ginkgo biloba extract for the treatment of intermittent claudication: a meta-analysis of randomized trials. Am J Med 2000; 108: 276-281.

(377) Pöntinen PJ, Salmela TM. Acupuncture treatment of migraine. In: Sicuteri F, Hrsg. Headache new vistas. Florenz: Biomedical Press, 1977: 251-256.


[Seite 188↓]

(378) Pradalier A, Serratrice G, Collard M et al. Double-blind controlled trial of long-acting propranolol in migraine prophylaxis. Cephalalgia 1989; 9 (suppl 10): 367-368.

(379) Pradalier A, Serratrice G, Collard M et al. Long-acting propranolol in migraine prophylaxis: results of a double-blind, placebo-controlled study. Cephalalgia 1989; 9: 247-253.

(380) Pradalier A, Serratrice G, Collard M et al. Beta-bloquants et migraine. Efficacité, contre placebo, du propranolol a libération prolongée. Thérapie 1990; 45: 441-445.

(381) Quandt J, Schmidt U, Schenk N. Ambulante Behandlung leichter und mittelschwerer depressiver Verstimmungen. Allgemeinarzt 1993; 2: 97-102.

(382) Rascol A, Montastruc JL, Rascol O. Flunarizine versus pizotifen: a double-blind study in the prophylaxis of migraine. Headache 1986; 26: 83-85.

(383) Rasmussen BK, Jensen R, Schroll M, Olesen J. Epidemiology of headache in a general population - a prevalence study. J Clin Epidemiol 1991; 44: 1147-1157.

(384) Raveau LC, Bousser MG. Le metoprolol, nouvel antimigraineux de fond. Presse Med 1988; 17: 1805-1809.

(385) Reh C, Laux P, Schenk N. Hypericum-Extrakt bei Depressionen - eine wirksame Alternative. Therapiewoche 1992; 42: 1576-1581.

(386) Renfrew MJ, Lang S. Do cabbage leaves prevent breast engorgement? (Cochrane Review). The Cochrane Library, issue 4, 1998. Oxford: Update Software.

(387) Resch KL, Ernst E. Wirksamkeitsnachweise komplementärer Therapien - Literaturanalyse am Beispiel der Akupunktur. Fortschr Med 1995; 113(5): 41-47.

(388) Rosen JA. Observations on the efficacy of propranolol for the prophylaxis of migraine. Ann Neurol 1983; 13: 92-93.

(389) Rosted P. The use of acupuncture in dentistry: a review of the scientific validity of published papers. Oral Diseases 1998; 4: 100-104.

(390) Roth C. Literature review and critical analysis on the topic of "in- and detoxication experiments in homoeopathy". Berl J Res Hom 1991; 1,2: 111-117.

(391) Ruschitzka F, Meier PJ, Turina M, Lüscher T, Noll G. Acute heart transplant rejection due to Saint John's wort. Lancet 2000; 355: 548-549.


[Seite 189↓]

(392) Ryan RE. Comparative study of nadolol and propranolol in prophylactic treatment of migraine. Am Heart J 1984; 108: 1156-1159.

(393) Sargent J, Solbach P, Damasio H et al. A comparison of naproxen sodium to propranolol hydrochloride and a placebo control for the prophylaxis of migraine headache. Headache 1985; 25: 320-324.

(394) Sartory G, Muller B, Metsch J, Pothmann R. A comparison of psychological and pharmacological treatment of pediatric migraine. Behav Res Ther 1998; 36: 1155-1170.

(395) Schellenberg R, Schwarz A, Niederberger U et al. Langzeitwirkung von Cyclandelat und Propanolol bei Migräne nach Beendigung einer viermonatigen medikamentösen Prophylaxe. Nervenheilkunde 1997; 16: 183-187.

(396) Schlich D, Braukmann F, Schenk N. Behandlung depressiver Zustände mit Hypericinium. Psycho 1987; 13: 440-447.

(397) Schmidt R, Oestreich W. Flunarizine in migraine prophylaxis: the clinical experience. J Cardiovasc Pharmacol 1991; 18 (suppl 8): S21-S26.

(398) Schmidt U, Harrer G, Kuhn U, Berger-Deinert W, Luther D. Wechselwirkungen von Hypericin-Extrakt mit Alkohol. Nervenheilkunde 1993; 12: 314-319.

(399) Schmidt U, Schenk N, Schwarz I, Vorberg G. Zur Therapie depressiver Verstimmungen. Psycho 1989; 15: 665-671.

(400) Schmidt U, Sommer H. Johanniskraut-Extrakt zur ambulanten Therapie der Depression. Fortschr Med 1993; 111: 339-342.

(401) Schneider B. Ginkgo-biloba-Extrakt bei peripheren arteriellen Verschlußkrankheiten. Meta-Analyse von kontrollierten klinischen Studien. Arzneim-Forsch/Drug Res 1992; 42: 428-436.

(402) Scholz E, Gerber WD, Diener HC, Langohr HD, Reinecke M. Dihydroergomtamine vs flunarizine vs nifidepine vs metoprolol vs propranolol in migraine prophylaxis: a comparative study based on time series analysis. In: Clifford Rose F, Hrsg. Advances in headache research. London: John Libbey, 1987: 139-145.

(403) Schrader E. Equivalence of St John's wort extract (Ze 117) and fluoxetine: a randomized, controlled study in mild-moderate depression. Intern Clin Psychopharmacol 2000; 15: 61-68.


[Seite 190↓]

(404) Schrader E, Meier B, Brattström A. Hypericum treatment of mild-moderate depression in a placebo-controlled study. A prospective, double-blind, randomized, placebo-controlled, multicentre study. Human Psychopharmacol 1998; 13: 163-169.

(405) Schulz H, Jobert M. Der Einfluß von Johanniskraut auf das Schlaf-EEG bei älteren Probandinnen. Nervenheilkunde 1993; 12: 323-327.

(406) Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. JAMA 1995; 273: 408-412.

(407) Shelton RC, Keller MB, Gelenberg A et al. Effectiveness of St John's wort in major depression. A randomized controlled trial. JAMA 2001; 285: 1978-1986.

(408) Shifman AC. The clinical response of 328 private patients to acupuncture therapy. Am J Chin Med 1975; 3, 165-179.

(409) Shimell CJ, Fritz VU, Levien SL. A comparative trial of flunarizine and propranolol in the prevention of migraine. S Afr Med J 1990; 77: 75-77.

(410) Silagy C. Developing a register of randomised controlled trials in primary care. BMJ 1993; 306: 897-900.

(411) Silagy C, Neil A. Garlic as a lipid lowering agent - a meta-analysis. J Roy Coll Phys 1994; 28: 39-45.

(412) Silagy C, Neil HAW. A meta-analysis of the effect of garlic on blood pressure. J Hypertens 1994; 12: 463-468.

(413) Sindrup SH, Madsen C, Bach FW, Gram LF, Jensen TS. St. John's wort has no effect on pain in polyneuropathy. Pain 2000; 91: 361-356.

(414) Smith GD, Egger M, Phillips AN. Beyond the grand mean? BMJ 1997; 315: 1610-1614.

(415) Smith LA, Oldman AD, McQuay HJ, Moore RA. Teasing apart quality and validity in sytematic reviews: an example from acupuncture trials in chronic neck pain. Pain 2000; 86: 119-132.

(416) Sold-Darseff J, Leydhecker W. Akupunktur bei Schmerzen im Kopfbereich sowie bei Blepharospasmus ohne organische Ursache. Klin Monatsbl Augenheilkd 1986; 189: 167-169.

(417) Solomon GD. Comparative efficacy of calcium antagonist drugs in the prophylaxis of migraine. Headache 1985; 25: 368-371.


[Seite 191↓]

(418) Solomon GD, Scott AFB. Verapamil and propranolol in migraine prophylaxis: A double-blind, cross-over study. Headache 1986; 26: 325.

(419) Sommer H, Harrer G. Placebo-kontrollierte Studie zur Wirksamkeit eines Hypericumpräparates bei 105 Patienten mit Depressionen. Nervenheilkunde 1993; 12: 274-277.

(420) Sommer H, Harrer G. Placebo-controlled double-blind study examining the effectiveness of a hypericum preparation in 105 mildly depressed patients. J Geriatr Psychiatry Neurol 1994; 7 (suppl 1): S9-S11.

(421) Sörensen PS, Hansen K, Olesen J. A placebo-controlled, double-blind, cross-over trial of flunarizine in common migraine. Cephalalgia 1986; 6: 7-14.

(422) Sörensen PS, Larsen BH, Rasmussen MJ et al. Flunarizine versus metoprolol in migraine prophylaxis: a double-blind, randomized parallel group study of efficacy and tolerability. Headache 1991; 31: 650-657.

(423) Sovak M, Kunzel M, Sternbach RA, Dalession DJ. Mechanism of the biofeedback therapy of migraine: Volitional manipulation of the psychophysiological background. Headache 1980; 21: 89-92.

(424) Soyka D, Oestreich W. Flunarizin versus Propranolol in der Intervallprophylaxe der Migräne - eine multizentrische Doppelblindstudie in 12 Kliniken. Nervenheilkunde 1987; 6, 177-183.

(425) Soyka D, Oestreich W. Therapeutic effectiveness of flunarizine and propranolol in the interval therapy of migraine. Cephalalgia 1987; 7 (suppl 6): 467-468.

(426) Soyka D, Oestreich W. Flunarizin versus Propranolol in der Intervallbehandlung der Migräne - Multizentrische Doppelblindstudie bei niedergelassenen Allgemeinärzten und Internisten. Nervenheilkunde 1990; 9: 45-49.

(427) Spielberger E. Johanniskraut-Präparat lindert selbst mittelschwere Depressionen. Ärztliche Praxis 1985; 37: 2546-2547.

(428) Spierings EL, Messinger HB. Flunarizine vs. pizotifen in migraine prophylaxis: a review of comparative studies. Cephalalgia 1988; 8 (suppl 8): 27-30.

(429) Spoerel WE, Verkey M, Leung CY. Acupuncture in chronic pain. Am J Chin Med 1976; 4: 267-279.


[Seite 192↓]

(430) Staffeldt B, Kerb R, Brockmöller J, Ploch M, Roots I. Pharmakokinetik von Hypericin und Pseudohypericin nach oraler Einnahme des Johanniskraut-Extrakts LI 160 bei gesunden Probanden. Nervenheilkunde 1993; 12: 331-338.

(431) Standnes B. The prophylactic effect of timolol versus propranolol and placebo in common migraine: beta-blockers in migraine. Cephalalgia 1982; 2: 165-170.

(432) Steardo L, Bonuso S, Di-Stasio E, Marano E. Selective and non-selective beta-blockers: are both effective in prophylaxis of migraine? A clinical trial versus methysergide. Acta Neurol Napoli 1982; 4: 196-204.

(433) Steardo L, Marano E, Barone P, Denman DW, Monteleone P, Cardone G. Prophylaxis of migraine attacks with a calcium-channel blocker: flunarizine versus methysergide. J Clin Pharmacol 1986; 26: 524-528.

(434) Steger W. Depressive Verstimmungen. Z Allgemeinmed 1985; 61: 914-918.

(435) Steiner TJ, Joseph R, Hedman C, Rose FC. Metoprolol in the prophylaxis of migraine: parallel-groups comparison with placebo and dose-ranging follow-up. Headache 1988; 28: 15-23.

(436) Stensrud P, Sjaastad O. Short-term clinical trial of propranolol in racemic form (Inderal), D-propranolol and placebo in migraine. Acta Neurol Scand 1976; 53: 229-232.

(437) Stensrud P, Sjaastad O. Comparative trial of Tenormin (atenolol) and Inderal (propranolol) in migraine. Ups J Med Sci Suppl 1980; 31: 37-40.

(438) Stensrud P, Sjaastad O. Comparative trial of Tenormin (atenolol) and Inderal (propranolol) in migraine. Headache 1980; 20: 204-207.

(439) Sterne JAC, Egger M. Funnel plots for detecting bias in meta-analysis: Guidelines on choice of axis. J Clin Epidemiol 2001; 54: 1046-1055.

(440) Sterne JAC, Egger M, Smith GD. Investigating and dealing with publication and other biases. In: Egger M, Smith GD, Altman DG, Hrsg. Systematic reviews in health care: meta-analysis in context. London: BMJ Books, 2001: 189-210.

(441) Stevinson C, Ernst E. Hypericum for depression. An update of the clinical evidence. Neuropsychopharmacology 1999; 9: 501-505.

(442) Stevinson C, Ernst E. Valerian for insomnia: a systematic review of randomized clinical trials. Sleep Medicine 2000; 1: 91-99.


[Seite 193↓]

(443) Stevinson C, Pittler MH, Ernst E. Garlic for treating hypercholesterinemia - a meta-analysis of randomized clinical trials. Ann Intern Med 2000; 133: 420-429.

(444) Stux G. Treatment of migraine with acupuncture and moxibustion. Acup Med 1987; 4(2): 6.

(445) Sudilovsky A, Elkind AH, Ryan-RE S, Saper JR, Stern MA, Meyer JH. Comparative efficacy of nadolol and propranolol in the management of migraine. Headache 1987; 27: 421-426.

(446) Taneri Z. Flunarizin versus Cyclandelat. TW Neurologie Psychiatrie 1998; 12: 429-430.

(447) Tavola T, Gala C, Conte G, Invernizzi G. Traditional Chinese acupuncture in tension-type headache: a controlled study. Pain 1992; 48: 325-329.

(448) Taylor MA, Reilly D, Llewllyn-Jones RH, McSharry C, Aitchison SH. Randomised controlled trials of homoeopathy versus placebo in perennial allergic rhinitis with overview of four trial series. BMJ 2000; 321: 471-476.

(449) ter Riet G, Kleijnen J, Knipschild P. Acupunctur en nekpijn/rugpijn. Huisarts en wetenschap 1989; 32: 223-227.

(450) ter Riet G, Kleijnen J, Knipschild P. Acupunctuur bij migraine en spanningshoofdpijn. Huisarts en wetenschap 1989; 32: 258-263.

(451) ter Riet G, Kleijnen J, Knipschild P. Acupunctuur en aangezichtspijn. Huisarts en wetenschap 1989; 32: 264-266.

(452) ter Riet G, Kleijnen J, Knipschild P. Acupunctuur en astma. Huisarts en wetenschap 1989; 32: 267-272.

(453) ter Riet G, Kleijnen J, Knipschild P. Acupunctuur en reumatoide artritis. Huisarts en wetenschap 1989; 32: 228-229.

(454) ter Riet G, Kleijnen J, Knipschild P. Acupunctuur en stoppen met roken. Huisarts en wetenschap 1989; 32: 299-303.

(455) ter Riet G, Kleijnen J, Knipschild P. Acupuntuur en chronische pijn. Huisarts en wetenschap 1989; 32: 230-238.

(456) ter Riet G, Kleijnen J, Knipschild P. A meta-analysis of studies into the effect of acupuncture in addiction. Br J Gen Prac 1990; 40: 379-382.

(457) ter Riet G, Kleijnen J, Knipschild P. Acupuncture and chronic pain: a criteria-based meta-analysis. J Clin Epidemiol 1990; 43: 1191-1199.


[Seite 194↓]

(458) Tfelt-Hansen P. Efficacy of beta-blockers in migraine. A critical review. Cephalalgia 1986; 6 (suppl 5): 15-24.

(459) Tfelt-Hansen P, Standnes B, Kangasneimi P, Hakkarainen H, Olesen J. Timolol vs propranolol vs placebo in common migraine prophylaxis: a double-blind multicenter trial. Acta Neurol Scand 1984; 69: 1-8.

(460) Thomas M, Behari M, Ahuja GK. Flunarizine in migraine prophylaxis: an Indian trial. Headache 1991; 31: 613-615.

(461) Thompson SG. Why sources of heterogeneity in meta-analysis should be investigated. BMJ 1994; 309: 1351-1355.

(462) Tolksdorf W, Klimm J, Klimczyk K, Penninger M. Die Akupunktur zur Behandlung chronischer Kopfschmerzen. Eine prospektive Studie zum Einfluss der Depression auf den Behandlungserfolg. Dtsche Ztschr Akup 1988; 31: 104-109.

(463) Turk Z, Moser I. Heilung des chronischen Kopfschmerzes durch Akupunktur. Erfahrungsheilkunde 1990; 39: 724-726.

(464) Turner P. Beta-blocking drugs in migraine. Postgrad Med J 1984; 60 (suppl 2): 51-55.

(465) Van Tulder MW, Cherkin DC, Berman B, Lao L, Koes BW. The effectiveness of acupuncture in the management of acute and chronic low back pain. Spine 1999; 24: 1113-1123.

(466) Van Tulder MW, Cherkin DC, Berman B, Lao L, Koes BW. Acupuncture for low back pain (Cochrane Review). The Cochrane Library, issue 1, 2000. Oxford: Update Software.

(467) Van Tulder MW, Koes BW, Bouter LM. Low back pain in primary care. Effectiveness of diagnostic and therapeutic interventions. Amsterdam: EMGO Institute, 1996.

(468) Verhagen AP, de Vet HCW, de Bie RA, Boers M, van den Brandt PA. The art of quality assesment of RTCs included in systemic reviews. J Clin Epidemiol 2001; 54: 651-654.

(469) Verhagen AP, de Vet HCW, de Bie RA, Kessels AG, Boers M, Bouter LM. The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus. J Clin Epidemiol 1998; 51: 1235-1241.


[Seite 195↓]

(470) Vernon H, McDermaid CS, Hagino C. Systematic review of randomized clinical trials of complementary/alternative therapies in the treatment of tension-type and cervicogenic headache. Compl Ther Med 1999; 7: 142-155.

(471) Verspeelt J, De-Locht P, Amery WK. Post-marketing cohort study comparing the safety and efficacy of flunarizine and propranolol in the prophylaxis of migraine. Cephalalgia 1996; 16: 328-336.

(472) Verspeelt J, De-Locht P, Amery WK. Postmarketing study of the use of flunarizine in vestibular vertigo and in migraine. Eur J Clin Pharmacol 1996; 51: 15-22.

(473) Vickers A, Goyal N, Harland R, Rees R. Do certain countries produce only positive results? A systematic review of controlled trials. Contr Clin Trials 1998; 19: 159-166.

(474) Vickers AJ. Can acupuncture have specific effects on health? A systematic review of acupuncture antiemesis trials. J Roy Soc Med 1996; 89: 303-311.

(475) Vickers AJ, Smith C. Analysis of the evidence profile of the effectiveness of complementary therapies in asthma: a qualitative survey and systematic review. Compl Ther Med 1997; 5: 202-209.

(476) Vickers AJ, Smith C. Homoeopathic Oscillococcinum for preventing influenza and influenza-like syndromes (Cochrane Review). The Cochrane Library, issue 1, 2000. Oxford: Update Software.

(477) Vilming S, Standnes B, Hedman C. Metoprolol and pizotifen in the prophylactic treatment of classical and common migraine. A double-blind investigation. Cephalalgia 1985; 5: 17-23.

(478) Vincent CA. A controlled trial of the treatment of migraine by acupuncture. Clin J Pain 1989; 5: 305-312.

(479) Vincent CA. The treatment of tension headache by acupuncture: a controlled single case design with time series analysis. J Psychosom Res 1990; 34: 553-561.

(480) Vogler BK, Ernst E. Aloe vera: a systematic review of its clinical effectiveness. Br J Gen Pract 1999; 49: 823-828.

(481) Vogler BK, Pittler MH, Ernst E. Feverfew as a preventive treatment for migraine: a systematic review. Cephalalgia 1998; 18: 704-708.

(482) Vogler BK, Pittler MH, Ernst E. The efficacy of ginseng. A systematic review of randomised clinical trials. Eur J Clin Pharmacol 1999; 55: 567-575.


[Seite 196↓]

(483) Volz HP. Controlled clinical trials of Hypericum extracts in depressed patients - an overview. Pharmacopsychiatry 1997; 30 (suppl 2): 72-76.

(484) Volz HP, Eberhardt R, Grill G. Wirksamkeit und Verträglichkeit des Johanniskrautextraktes D-0496 bei leichten bis mittelschweren depressiven Episoden. Plazebokontrollierte Doppelblindstudie über 6 Wochen. Nervenheilkunde 2000; 19: 401-405.

(485) Volz HP, Laux P. Potential treatment for subthreshold and mild depression: a comparison of St. John's wort extracts and fluoxetine. Comprehensive Psychiatry 2000; 41 (suppl 1): 133-137.

(486) Vorbach EU, Arnoldt KH, Hübner WD. Efficacy and tolerability of St. John's wort extract LI 160 versus imipramine in patients with severe depressive episodes according to ICD-10. Pharmacopsychiatry 1997; 30 (suppl 2): 81-85.

(487) Vorbach EU, Hübner WD, Arnoldt KH. Wirksamkeit und Verträglichkeit des Hypericum-Extraktes LI 160 im Vergleich mit Imipramin. Nervenheilkunde 1993; 12: 290-296.

(488) Vorbach EU, Hübner WD, Arnoldt KH. Effectiveness and tolerance of the Hypericum extract LI 160 in comparison with imipramine: randomized double-blind study in 135 outpatients. J Geriatr Psychiatry Neurol 1994; 7 (suppl 1): 19-23.

(489) Walach H. Unpsezifische Therapie-Effekte. Das Beispiel Homöopathie. Habilitationsschrift, Psychologisches Institut, Albert-Ludwigs-Universität Freiburg, 1997.

(490) Warnecke G. Beeinflussung klimakterischer Depressionen. Z Allgemeinmed 1986; 62: 1111-1113.

(491) Warshafsky S, Kamer RS, Sivak SL. Effect of garlic on total serum cholesterol. Ann Intern Med 1993; 119: 599-605.

(492) Weber RB, Reinmuth OM. The treatment of migraine with propranolol. Neurology 1972; 22: 366-369.

(493) Weihmayr T, Ernst E. Die therapeutische Wirksamkeit von Crataegus. Fortschr Med 1996; 114: 27-29.

(494) Weinschütz T. Akupunktur bei Kopfschmerzen. Methodische Grundlagen und Ergebnisse klinischer Untersuchungen. Der Schmerz 1996; 10: 149-155.


[Seite 197↓]

(495) Weinschütz TK, Niederberger U. Zum Stellenwert der Akupunktur in der Migränetherapie. Methodische Grundlagen und Ergebnisse zweier kontrollierter, prospektiver klinischer Studien. Nervenheilkunde 1995; 14: 295-301.

(496) Weiß G, Kallischnigg G. Ginkgo-biloba-Extrakt (EGb 761) - Meta-Analyse von Studien zum Nachweis der therapeutischen Wirksamkeit bei Hirnleistungsstörungen bzw. peripherer arterieller Verschlußkrankheit. Münch med Wschr 1991; 10: 138-142.

(497) Werth W. Psychotonin M versus Imipramin in der Chriurgie. Der Kassenarzt 1989; 15: 64-68.

(498) Wettstein A. Cholinesterasehemmer und Ginkgoextrakte - in der Demenztherapie vergleichbar? Vergleich publizierter plazebokontrollierter Wirksamkeitsstudien von mindestens sechsmonatiger Dauer. Fortschr Med 19999; 117: 11-18.

(499) Wheatley D. LI 160, an extract of St. John's wort, versus amitriptyline in mildly to moderately depressed outpatients - a controlled 6-week clinical trial. Pharmacopsychiatry 1997; 30 (suppl 2): 77-80.

(500) White A, Eddleston C, Hardie R, Resch KL, Ernst E. A pilot study of acupuncture for tension headache, using a novel placebo. Acupunct Med 1996; 14: 11-15.

(501) White A, Ernst E. A trial method for assessing the adequacy of acupuncture treatments. Altern Ther Health Med 1997; 4: 66-71.

(502) White AR, Ernst E. A systematic review of randomized controlled trials of acupuncture for neck pain. Rheumatology 1999; 38: 143-147.

(503) White AR, Rampes H, Ernst E. Acupuncture for smoking cessation (Cochrane Review). The Cochrane Library, issue 4, 1999. Oxford: Update Software.

(504) White AR, Resch KL, Ernst E. Smoking cessation with acupuncture? A 'best evidence synthesis'. Forsch Komplementärmed 1997; 4: 102-105.

(505) White AR, Resch KL, Ernst E. A meta-analysis of acupuncture techniques for smoking cessation. Tobacco Control 1999; 8: 393-397.

(506) Wideroe TE, Vigander T. Propranolol in the treatment of migraine. BMJ 1974; 2: 699-701.

(507) Wienert V, Classen R, Hiller KO. Zur Frage der Photosensibilisierung von Hypericin in einer Baldrian-Johanniskraut-Kombination - klinisch-experimentelle, plazebokontrollierte Vergleichsstudie. Unpublizierter Bericht 1991.


[Seite 198↓]

(508) Wiesenauer M, Lüdtke R. A meta-analysis of the homeopathic treatment of pollinosis with Galphimia glauca. Forsch Komplementärmed 1996; 3: 85-90.

(509) Williams JW, Mulrow CD, Chiquette E, Noel PH, Aguilar C, Cornell J. A systematic review of newer pharmacotherapies for depression in adults: evidence report summary. Ann Intern Med 2000; 132: 743-756.

(510) Wilt TJ, Ishani A, MacDonald R, Stark G, Mulrow C, Lau J. Beta-sitosterols for benign prostata hyperplasia (Cochrane Review). The Cochrane Library, issue 1, 2000. Oxford: Update Software.

(511) Wilt TJ, Ishani A, MacDonald R, Stark G, Mulrow C, Lau J. Serenoa repens for treatment of benign prostata hyperplasia (Cochrane Review). The Cochrane Library, issue 1, 2000. Oxford: Update Software.

(512) Wilt TJ, Ishani A, Stark G, MacDonald R, Lau J, Mulrow C. Saw palmetto extracts for treatment of benign prostatic hyperplasia. A systematic review. JAMA 1998; 280: 1604-1609.

(513) Wilt TJ, MacDonald R, Ishani A, Rutks I, Stark G. Cernilton for benign prostata hyperplasia (Cochrane Review). The Cochrane Library, issue 2, 2000. Oxford: Update Software.

(514) Windeler J. Intention to treat - Begründung und Bedeutung. Int Praxis 1992; 32: 641-650.

(515) Winkel R, Koritsch HD, Piayda H, Trenckmann U. Phytopharmakotherapie der komorbiden depressiven Störungen bei Alkoholabhängigkeit - Wirksamkeit des Johanniskrautextraktes LI 160 bei komorbid-depressiv Alkoholerkrankten. In: Trenckmann U, Hrsg. Phytopharmaka und seelische Störungen. Neu-Isenburg: LinguaMed, 2000: 43-51.

(516) Winkel R, Koritsch HD, Piayda H, Trenckmann U. St. John's wort extract LI 160 in depressive, alcohol addicted patients. Phytomedicine 2000; 7 (suppl II): 19.

(517) Winther K, Hedman C, Flodgaard H. Platelet P1, P4-Di (adenosine-51) tetraphosphate (AP4A) in migraine patients before and during beta-adrenoceptor blockade. Eur J Clin Invest 1990; 20: 336-338.

(518) Witte B, Harrer G, Kaptan T, Podzuweit H, Schmidt U. Behandlung depressiver Verstimmungen mit einem hochkonzentrierten Hypericumpräparat -eine multizentrische plazebokontrollierte Doppelblindstudie. Fortschr Med 1995; 113: 404-408.


[Seite 199↓]

(519) Wober C, Wober BC, Koch G, Wessely P. Long-term results of migraine prophylaxis with flunarizine and beta-blockers. Cephalalgia 1991; 11: 251-256.

(520) Woelk H. Comparison of St John's wort and imipramine for treating depression: randomised controlled trial. BMJ 2000; 321: 536-539.

(521) Wong AHC, Smith M, Boon HS. Herbal remedies in psychiatric practice. Arch Gen Psychiatry 1998; 55: 1033-1044.

(522) Worz R, Drillisch C. Migräne-Prophylaxe durch einen Kalziumeintrittsblocker. Ergebnisse einer Doppelblindstudie Flunarizin vs. Pizotifen. Münch med Wschr 1983; 125: 711-714.

(523) Worz R, Reinhardt BB, Foh M, Grotemeyer KH, Scharafinski HW. Migräneprophylaxe durch Bisoprolol. Ergebnisse einer Doppelblindstudie versus Metoprolol. Fortschr Med 1992; 110: 268-272.

(524) Worz R, Reinhardt BB, Grotemeyer KH, Foh M. Bisoprolol and metoprolol in the prophylactic treatment of migraine with and without aura - a randomized double-blind cross-over multicenter study. Cephalalgia 1991; 11 (suppl 11): 152-153.

(525) Yamauchi N. The results of therapeutic acupuncture in a pain clinic. Can Anaesth Soc J 1976; 23: 196-206.

(526) Young GL, Jewell MD. Creams to prevent striae gravidarum (Cochrane Review). The Cochrane Library, issue 4, 1998. Oxford: Update Software.

(527) Yue QY, Bergquist C, Gerdén B. Safety of St John's wort (Hypericum perforatum). Lancet 2000; 355: 576-577.

(528) Zeller K. Once daily administration of Hypericum extract (STW 3): a convenient treatment. In: Chrubasik S, Roufogalis BD, Hrsg. Herbal medicinal products for the treatment of pain. Lismore: South Cross University Press, 2000: 164-168.

(529) Zibin D. Treating vascular migraine with deep puncture at fecgchi: a report of 240 cases. Int J Clin Acup 1994; 5: 455-458.

(530) Ziegler DK, Hurwitz A, Hassanein RS, Kodanaz HA , Preskorn SH, Mason J. Migraine prophylaxis. A comparison of propranolol and amitriptyline. Arch Neurol 1987; 44: 486-489.

(531) Ziegler DK, Hurwitz A, Preskorn S, Hassanein R, Seim J. Propranolol and amitriptyline in the prophylaxis of migraine. Pharmacokinetic and therapeutic effects. Arch Neurol 1997; 50: 825-830.


[Seite 200↓]

(532) Zwölfer W, Kaiser B, Cartellieri M, Spacek A. Behandlung des Spannungskopfschmerzes mit Akupunktur. Dtsche Ztschr Akup 1994; 37: 129-132.


© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
DiML DTD Version 3.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML-Version erstellt am:
04.08.2004